ABSTRACT We have examined the effects of various mannans, glycoproteins, oligosaccharides, monosaccharides, and sugar phosphates on the binding and phagocytosis of yeast cell walls (zymosan) by mouse peritoneal macrophages. A phosphonomannan (PO4:mannose ratio = 1:8.6) from K!oeckera brevis was the most potent inhibitor tested; it inhibited binding and phagocytosis by 50% at concentrations of ~3-5/~g/ml and 10 p,g/ml, respectively. Removal of the phosphate from this mannan by mild acid and alkaline phosphatase treatment did not appreciably reduce its capacity to inhibit zymosan phagocytosis. The mannan from Saccharomyces cerevisiae mutant LB301 inhibits phagocytosis by 50% at 0.3 mg/ml, and a neutral exocetlutar glucomannan from Pichia pinus inhibited phagocytosis by 50% at 1 mg/ml. Cell wall mannans from wild type S. cerevisiae X2180, its mnn2 mutant which contains mannan with predominantly 1 ---* 6-1inked mannose residues, yeast exocellular mannans and O-phosphonomannans were less efficient inhibitors requiring concentrations of t-5 mg/ml to achieve 50% reduction in phagocytosis. Horseradish peroxidase, which contains high-mannose type oligosaccharides, was also inhibitory.
Laboratories Inc., (Miami, FL); mannan from S. cerevisiae X2180 was from either Sigma Chemical Co. (St. Louis, MO) or Dr. Clinton Ballou of the University of California, Berkeley. Mannans from mutants of S. cerevisiae X2180, mnn2 (2l) and LB-301 (2), as well as phosphomannan 8.6 from KI brevis (28) were generous gifts of Dr. Clinton Ballou. Mannans were dialysed overnight against 1 N acetic acid and lyophilized before use. The structures of some of these mannans are shown in Fig. 1 . KI. brevis strain 55~15 was a generous gift of Dr. Herman Phaff of the University of California, Davis; KI. brevis zymosan particles were prepared by autoclaving a 25% (vol/vol) log phase KL brevis suspension in Dulbecco's phosphate-buffered saline without Ca ++ and Mg ÷÷ (PD), followed by reduction with mercaptoethanol and alkylation with iodoacetamide as described (17) . S. cerevisiae zymosan was purchased from Sigma Chemical Co. and washed as described (18) . Yeast exocellular mannans (23, 24) Mannose oligosaccharides were obtained from the acetolysis of S. cerevisiae mannan (Sigma Chemical Co.) by the method of Kocourek and Ballou (16) followed by chromatography on a column (2.5 x 100 cm) of P-2 (-400 mesh, Bio-Rad Laboratories, Richmond, CA) eluted with water at 48°C. The carbohydrate peaks were pooled, lyophilized, and analyzed by thin-layer chromatography on silica gel G plates developed with butanol/acetic acid/water (100:50:50) using stachyose, raffinose, melibiose, and manrtose as standards (14) . The individual oligosaccharides visualized by a-naphthol-sulphuric acid (14) were essentially homogeneous and migrated with Re values similar to the corresponding standards with the same degree of polymerization. The oligosaccharides did not contain any phosphate as determined by the method of Bartlett (3).
Cell Cultures: Mouse peritoneal macrophages were harvested by the method of Cohn and Benson (5) and plated on coverslips (13 mm diameter) in 35-mm dishes essentially as described (18) . Resident and proteose peptoneelicited (7) macrophages were plated at a density of 2 x 10 ~ peritoneal cells per coverslip. Thioglycollate-elicited macrophages were plated at a density of I x 106 ceils per 35-mm dish (18) . Macrophage cultures were incubated at 37°C for 16-24 h; before use, the coverslip cultures were washed as described below. For experiments employing PLL-, PLL-mannan-, and PLL-bovine serum albumin (PLL-BSA)-coated substrates, cells were plated on appropriately coated 13-ram coverslips (see below) in 16-mm Costar wells at 3 x 10 ' cells per well (19) in Eagle's minimal essential medium (MEM) with 10% FBS, incubated at 37°C for 4 h, and washed to remove nonadherent cells. Despite vigorous washing, many lymphocytes remained adherent to these PLL-, PLL-mannan-or PLL-BSAcoated coverslips. For this reason these cultures were further incubated at 37°C in MEM-10% FBS overnight. After this period the lympbocytes detached, leaving a population of viable, well-spread cells >95% of which are macrophages. For experiments using macrophages on untreated coverslips, cells were plated at the densities described above in MEM-10% FBS for 4 h at 37°C, washed twice with MEM, and incubated in MEM-10% FBS overnight.
Binding and Phagocytosis Assays:
Prior to use, coverslip cultures were washed by dipping in cold MEM and placed in 16-mm Costar wells with 0.5 ml of medium containing MEM and 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) (pH 7A) with or without inhibitors as appropriate and preincubated for 15 min at 4°C for binding assays or at 37°C for phagocytosis assays. For binding, 20 ~tl of a 5% (vol/vol) suspension of particles was added per well and attachment was allowed to proceed for 60-90 min at 4°C. For phagocytosis, 20/~1 of a 2% (vol/vol) suspension of particles was added to each well for 30 min at 37°C. Phagocytosis of IgG-coated erythrocytes was measured as described (18) . At the end of the experiment the cultures were washed with PD and fixed in 2.5% glutaraldehyde in PD. Ingestion and binding were scored with a phase-contrast microscope by counting the number of particles bound or ingested by 100 macrophages. Under phase-contrast optics, ingested zymosan particles can be readily distinguished from bound particles by the location of the whole particle within the periphery of the macrophage, by the loss of the characteristic grayish color of uningested particles, and by the presence of a vacuole around the particle. The binding of complement-coated erythrocytes, prepared as described (4) , was performed by adding 20 /d of 5% (vol/vol) complement-coated erythrocytes to resident macrophages on coverslips in 500 #i of MEM-25 mM HEPES, pH 7.4-2% FBS. The cultures were incubated at 37°C for 30 min, washed in PD, and fixed in 2.5% glutaraldehyde in PD. The phagocytic or binding index is defined as the number of particles ingested or bound by 100 macrophages.
Preparation of Coverslips Coated with Poly-t-lysine, Poly~t-lysine-bovine Serum Albumin and Poly-L-lysine-mannan:
Poly-L-lysine-coated coverslips were prepared by the method of Michl et al. (19) . Mannan from S. cerevisiae was clarified by centrifugation of a 100 mg per ml aqueous solution at 23,000 g for 20 min; the mannan in the supernatant was reprecipitated with Fehling's solution, washed in methanol/acetic acid (5/1), dialyzed against 1 N acetic acid, and lyophilized (16) . 100 ~1 of a solution containing 50 mg/ml BSA or mannan and 10 mg/ml of l-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride were layered over PLL-coated coverslips and incubated at 4°C overnight. The amount of mannan or BSA coupled was quantitated by adding 1 x 107 cpm of iodinated mannan (2.3 x 10 r' cpm/~tg) or BSA (4.4 x 10 s cpm/~g) to each ml of the coupling mixture and counting the coverslips for radioactivity. ~4.3 +_ 0.8/~g mannan or 9.0 + 3.0/zg BSA were coupled per coverslip.
Mild Acid Hydrolysis and Alkaline Phosphatase Treatment
of Mannan: KI. brevis mannan (20 mg in 1 ml of 0.01 M HC1) was hydrolysed for 30 min at 100°C, dialyzed exhaustively against water, and lyophilized. 8 mg of this acid-hydrolysed mannan was dissolved in 0.8 ml of 0.75 M Tris HCI, pH 8.0 and incubated with 49 U of E. coil alkaline phosphatase (sp act 31 U/mg) at 37 ° for 24 h. The reaction was terminated by incubating the mixture for 3 rain in a boiling water bath. The mannan was dialyzed exhaustively against 1 M acetic acid and lyophilized. The carbohydrate and phosphorus content of each preparation was quantitated. The mannose/phosphate ratio was 9.1 for the initial mannan, 8.2 for the acid-treated mannan, and 23.5 for the mild acid-and alkaline phosphatase-treated mannan. The final product contained about 35% of the phosphate of the acid-treated mannan.
General Methods: lodination of mannan and BSA was performed as described (11) . Phosphorus content of mannan was measured by the method of Bartlett (3) . Carbohydrates were quantitated by the phenol-sulphuric acid method (6) . Alkaline phosphatase activity was measured as described in the Worthington Enzyme manual.
Ceils for trypsinization were washed three times with MEM, followed by treatment with 1 mg/ml trypsin in MEM-25 mM HEPES, pH 7.4 at 37°C for 30 min. The trypsin-containing medium was aspirated and excess trypsin neutralized with MEM-10% FBS. Cells were washed twice again with MEM before use.
For chloroquine inhibition assays, 8 x 104 resident macrophages were plated on 13-mm coverslips in MEM-10% FBS, incubated overnight, washed two times with MEM, and incubated in 16-ram Costar wells for 1 h at 37°C in 500 #1 of MEM containing 25 mM HEPES (pH 7.4), 2% FBS to which chloroquine and 1 or 10 mg/ml S. cerevisiae mannan were added as indicated. The ceils were then washed three times with cold MEM and further incubated at 37°C in control or chloroquine-containing medium to which S. cerevisiae or KI. brevis zymosan was added to measure phagocytosis and binding, respectively.
RESULTS AND DISCUSSION
To identify oligosaccharides that might be useful as probes of the macrophage zymosan uptake system we screened a number of mannans for their capacity to inhibit phagocytosis of S. cerevisiae zymosan. Significant inhibition of zymosan phagocytosis was observed with mannans from KI. brevis, wild type, and sugar transferase mutants of S. cerevisiae, and Pichiapinus (Table I) . Other exocellular mannans and phosphomannan monoesters obtained from Hansenula capsulata, Torulopsis pinus, Pichia sp., Hansenula minuta, and Pichia raucosa were weak inhibitors (data not shown).
To explore further the relationship between mannan structure and inhibitory potency we studied the dose dependence of inhibition of zymosan uptake by mannans from wild type and mutant S. cerevisiae. Mannan from wild type S. cerevisiae at a concentration of 1 mg/ml inhibited zymosan ingestion by -50% (Fig. 2) . Mannan from the S. cerevisiae mnn2 mutant, which has a 1 ---, 6-1inked linear array of mannosyl residues in its outer chain but lacks the 1 ---> 2-and 1 ~ 3-1inked mannosyl oligosaccharide branches found in wild type mannan (Fig. 1) , was about twofold less effective than wild type mannan ( :m~o: more potent than wild type or mnn2 mannan as a phagocytosis inhibitor. The most effective phagocytosis inhibitor was a mannan fraction with a mannose:phosphate ratio of 8.6:1 purified from KI. brevis (28) . It is at least two orders of magnitude better, on a weight basis, than wild type S. cerevisiae mannan in inhibiting zymosan phagocytosis (Fig. 2) .
Inflammatory macrophages elicited with thioglycollate medium or proteose peptone broth are larger and more phagocytic (4) than resident macrophages. To determine whether mannan affects zymosan uptake by these cells we incubated them with S. cerevisiae zymosan in the presence of varying amounts of KI. brevis or S. cerevisiae mannans. Both types of mannan inhibited zymosan ingestion by thioglycollate-elicited and proteose peptone-elicited macrophages (Fig. 3) . However, the two types of inflammatory macrophages differed in their susceptibility to mannan inhibition of zymosan uptake. Thioglycollateelicited macrophages were inhibited by lower concentrations of mannan than were resident macrophages, whereas the reverse was observed with proteose peptone-elicited macrophages (Fig. 3) their source and the agents used to elicit them. Similarly, the data in Fig. 3 suggest that the number and/or affinity of macrophage receptors for zymosan varies, depending upon the agent used to elicit the macrophages.
Mannans Selectively Inhibit Phagocytosis of Zymosan
To determine whether mannans are general inhibitors of macrophage phagocytosis, or whether they act selectively on a subset of macrophage membrane receptors, we incubated resident macrophages with IgG-coated sheep erythrocytes in the presence of varying concentrations of KI. brevis mannan. This mannan inhibited phagocytosis of S. cerevisiae zymosan, but had no inhibitory effect on Fc receptor-mediated ingestion of IgG-coated erythrocytes (Fig. 4) . This experiment indicates that mannans do not inhibit phagocytosis per se; it suggests that the mannans affect a specific subset of receptors on the macrophage surface.
Mannans Inhibit Binding of Zymosan to the Macrophage
S. cerevisiae zymosan does not bind efficiently to macrophages at 4°C (<250 particles bound per 100 resident or proteose peptone-elicited macrophages). Because KI. brevis mannan is a much more potent inhibitor of zymosan uptake than S. cerevisiae mannan, we reasoned that cell walls prepared from Kl. brevis might have a higher affinity for the macrophages than S. cerevisiae zymosan. Indeed, when KI. brevis zymosan was incubated with macrophages at 4°C, the KI. brevis zymosan was bound efficiently to the macrophages. Resident and proteose peptone-elicited macrophages bound 390 __. 130 and 420 +_ 160 KI. brevis zymosan particles per 100 macrophages, respectively, whereas thioglycollate-elicited macrophages bound 200 ---150. Thus, consistent with the results described in Fig. 3 , thioglycollate-elicited macrophages bind fewer zymosan particles than resident or proteose peptoneelicited macrophages.
KI. brevis mannan is a much more potent inhibitor than S. cerevisiae mannan of binding of KI. brevis zymosan to macrophages. The concentration causing 50% inhibition of KI. brevis zymosan binding to proteose peptone-elicited macrophages was ~100/tg/ml for S. cerevisiae mannan and ~3-5/tg/ml for KI. brevis mannan. KI. brevis mannan completely inhibited the binding of KL brevis zymosan to resident, thioglycollate-elicited, and proteose peptone-elicited macrophages at concentrations above 20/~g/ml (data not shown).
Modulation of Mannan Receptors by Substrate Adherent Ligands
The results presented to this point confirm that specific mannan-inhibitable receptors mediate the binding of zymosan particles to the macrophage surface; they suggest that these receptors mediate the internalization of zymosan particles as well. To examine these issues further we have examined the effects of ligand-coated surfaces on zymosan uptake, a technique that has proved useful in analyzing the physiology of macrophage Fc and complement receptors (19) and of the chicken hepatocyte galactose-binding receptor (33) . Macrophages were plated on coverslips coated with PLL to which mannan was cross-linked; the macrophages were then incubated at 37°C with zymosan particles. Few of the macrophages plated on these mannan-coated coverslips for 2 h before the addition of zymosan ingested any of these particles (Table II) . Macrophages incubated on PLL-mannan for 24 h before the addition of zymosan gave qualitatively similar results (Table  II) . In contrast, the capacity of macrophages plated on PLLmannan to bind complement-coated erythrocytes and to ingest IgG-coated erythrocytes was unimpaired (Table II) . These results confirm that the receptors that mediate zymosan binding and ingestion can be modulated by substrate adherent ligands without altering the activities of other classes of macrophage membrane receptors (i.e. Fc and complement receptors); moreover, in conjunction with the data in Fig. 4 they show that these receptor systems operate independently of one another.
Chloroquine Inhibits Zymosan Phagocytosis
Chloroquine elevates macrophage intralysosomal pH (20) and promotes "down regulation" ofmacrophage Man/GlcNAc receptors (29) , presumably by trapping the receptors within intracellular compartments (12, 29) . As shown in Fig. 5a , chloroquine inhibits zymosan phagocytosis in a dose-dependent manner, reaching 75% inhibition at 250/zM. Preincubation of macrophages in chloroquine enhances its inhibitory effect. The inhibitory effect of chloroquine was further increased by including mannan in the preincubation medium. Under these last conditions, 10/.tM chloroquine was sufficient to produce 50% inhibition of zymosan phagocytosis.
Macrophages incubated at 4°C with 250 /~M chloroquine bind as many KL brevis zymosan as control macrophages, indicating that the drug does not interfere directly with the interaction of zymosan with macrophage receptors. As expected, macrophages preincubated at 37°C for 1 h with 100 /~M chloroquine exhibited a 95% reduction in binding of KI. brevis zymosan (data not shown).
In all cases, the inhibitory effects of chloroquine, or of chloroquine plus mannan, on zymosan binding (data not shown) and phagocytosis (Fig. 5 b) were reversible. Chloroquine had no effect on the activity of other macrophage surface receptors examined. For instance, treatment of resident mac- rophages with chloroquine or with chloroquine plus mannan did not alter binding or ingestion of IgG-coated erythrocytes (data not shown), confirming again (cf. Fig. 4 ) that the receptor that mediates zymosan uptake functions independently of other macrophage receptor systems.
Zymosan Uptake is Abolished by Trypsin and Reduced by Calcium Chelation
The capacity of rat alveolar macrophages to bind mannose-BSA and Candida krusei is inhibited by trypsin treatment of the macrophages or by chelation of Ca ++ in the medium (26, 32) . Incubation of resident macrophages with trypsin reduced the capacity of these ceils to bind and ingest S. cerevisiae zymosan by 93% and 72% (mean of three experiments), respectively (data not shown). Incubation of macrophages in calcium- free medium had no inhibitory effect on zymosan binding or phagocytosis. In contrast, addition of EGTA to the medium caused a 52-61% decrease in zymosan binding and a 43-45% decrease in zymosan ingestion by macrophages. The inhibitory effects of EGTA were overcome when excess Ca ++ was added to the medium. The Man/GlcNAc receptor described by Townsend and Stahl (30) requires Ca ++ for ligand binding. Thus the failure of EGTA to completely block zymosan binding and ingestion might result from participation of another receptor system in this process. The mannose phosphate receptor described by Kaplan et al. (15) has no Ca ++ requirement for ligand binding. To determine whether this receptor has any role in zymosan uptake, we incubated resident macrophages with EGTA and 1 mg/ml phosphomannan monoester from Hansenula holstii or 25 mM mannose-6-phosphate. Addition of these phosphorylated saccharides did not enhance the inhibitory effect of EGTA (data not shown).
Macrophage Receptors that Mediate Zymosan Uptake Recognize Neutral and Not Phosphorylated Mannans
To search further for a possible role for a mannose phosphate receptor in zymosan uptake we compared the effects of mannose-6-phosphate and mannose phosphate-containing oligosaccharides with mannose, mannose-containing oligosaccharides, dephosphorylated mannan, and a mannose-containing glycoprotein on zymosan binding and phagocytosis. 50 mM mannose-6-phosphate was slightly less inhibitory than equal concentrations of mannose or mannobiose (Table III) . None of these saccharides was an effective inhibitor of zymosan binding or ingestion. Mannotriose and mannotetraose, derived from the acetolysis of S. cerevisiae mannan, were good inhibitors at 50 mM (Table III) but were roughly comparable to mannose in inhibitory potency when their concentrations were corrected for their mannose content (e.g. l0 mM mannotetraose equals 40 mM mannose). D-Glucose, L-fucose and o-galactose at 50 mM had no effect on either the binding or phagocytosis of zymosan by macrophages (data not shown).
To examine the effect of mannan phosphorylation on zymosan uptake we used mild acid hydrolysis and alkaline phosphatase to degrade KL brevis mannan (mannose:phosphate ratio = 8.6: l) in a stepwise fashion. Mild acid treatment resulted in only a small reduction in the inhibitory potency of Kl. brevis mannan (Fig. 6) . Alkaline phosphatase treatment of this acidhydrolyzed mannan removed 65% of the phosphate groups but caused no further change in the inhibitory potency of the, mannan (Fig. 6) .
In a related series of experiments, exocellular mannans with high phosphate content that had been hydrolysed with mild acid to expose their mannose-6-phosphate groups were tested for their ability to inhibit the phagocytosis of zymosan particles by macrophages. They were no more inhibitory than the corresponding neutral mannans (Table I) . O-Phosphonomannan monoesters, such as one from Hansenula holstii that potently inhibits fl-glucuronidase uptake by the fibroblast man- nose-6-phosphate receptor (50% inhibition = 0.2 #g/ml [reference 10]), were also ineffective. On a weight basis, the best inhibitors of phagocytosis among several exocellular mannans tested were the O-phosphonoglucomannan and the neutral glucomannan from Pichia pinus. Pichia pinus mannan contains almost exclusively glucose as the nonreducing end group (24) . A glucogalactan from Sporobolomyces sp. (23) that has predominantly glucose at the nonreducing terminal and contains no mannose also inhibited phagocytosis to an appreciable extent (Table I) . Thus glucose appears to compete for the binding site for zymosan particles.
Horseradish peroxidase is reported to contain no phosphorylated oligosaccharides (34), and we have confirmed that the peroxidase used in our experiments has no detectable phosphate. It is a very effective inhibitor of zymosan binding and phagocytosis (Table III) . Moreover, in experiments to be reported elsewhere, we have found that pinocytosis of HRP by mouse macrophages can be inhibited to a significant degree by mannan. Thus mannan and HRP bind to the receptors exhibiting similar ligand specificity.
In summary, the results reported here show that zymosan binding and phagocytosis can be inhibited by micromolar concentrations of KI. brevis mannan and by somewhat higher concentrations of other mannose-containing oligosaccharides and glycoproteins; that phosphorylated mannose residues do not contribute to the inhibitory effects of the saccbarides or glycoproteins used in these experiments; that the macrophage surface structures that mediate zymosan uptake can be modulated by substrates coated with mannan; that they can be "down regulated" by mannan in the presence of chloroquine, destroyed by trypsin, and inhibited by Ca ++ chelation. These treatments have no effect on the binding or phagocytosis of IgG-coated erythrocytes by macrophage Fc receptors. These findings indicate that zymosan binding and phagocytosis are mediated by a specific membrane receptor and that the receptor is similar in its ligand-binding requirements, trypsin sensitivity, and requirement for Ca ++ to the Man/GlcNAc receptor described by Stahl and his colleagues (25, 26) . We conclude that zymosan uptake is mediated by this Man/GlcNAc receptor. Thus the mannose receptor, like the Fc and complement receptors (27, 31) , mediates both adsorptive pinocytosis of soluble molecules and phagocytosis of particulate materials.
